Search 

Meet Seda at the UK Pavilion (Hall B, Stand 2348).

Seda Pharmaceutical Development Services provides integrated Pharmaceutical Development and Clinical Pharmacology services to the Biotech sector. We enable rapid and efficient development of optimal medicinal products, from conventional to complex, through pragmatic and coherent scientific excellence. Seda was founded in 2015, and has since demonstrated exceptional growth and expansion in our capabilities which include consultancy, laboratory, and pharmacokinetic modelling services. We provide clients with the experience and expertise found in the development functions of major pharmaceutical companies but with the speed and flexibility required by fast moving Biotechs. Headquartered in Greater Manchester, UK, our bespoke laboratory and office complex is well equipped for the rapid design, development and evaluation of prototype formulation options, from preformulation services, to development of preclinical and clinical formulations. Enhancing the value proposition of our clients is our contribution to bringing new, innovative therapies to patients rapidly and successfully.

Meet Touchlight at the UK Pavilion (Hall B, Stand 2348).

Touchlight is a privately-owned CDMO based in London, U.K., focused on the provision of DNA services and manufacture of enzymatically produced doggybone DNA (dbDNA™) to enable the development of genetic medicines. Touchlight provide rapid, enzymatic DNA development and manufacturing for all advanced therapy production, including mRNA, viral and non-viral gene therapy and DNA API. dbDNA is a minimal, linear, covalently closed structure, which eliminates bacterial sequences. Touchlight’s revolutionary enzymatic production platform enables unprecedented speed, scale, and the ability to target genes with a size and complexity that is impossible with current technologies. Clients can be supported from pre-clinical through development and supply, to licencing and tech transfer for use in-house.

Meet UKRI - STFC at the UK Pavilion (Hall B, Stand 2348).

Harwell Campus is a UK Research and Development powerhouse and designated Life Sciences Opportunity Zone near Oxford. It's recognised for world-leading imaging technologies, advancements in xRNA and nucleic acid therapies, vaccines, LNPs, diagnostics and AI-enhanced analytics. Pioneering a multidisciplinary cluster model, Harwell’s Health Tech Cluster brings together industry, academia, public bodies and investors, with £3bn of open access National research facilities, to commercialise and accelerate innovation. Home to organisations like Moderna, Catalent, Agilent, Vaccitech and Diamond Light Source (UK Synchrotron), Harwell is growing with plans for a further 1.5 m sq.ft. of developments.

Building on this success, Sci-Tech Daresbury proudly hosts England’s north-west Health Tech Cluster. Connecting local and national government, industry, NHS organisations, universities and Research and Development assets including the Hartree National Centre for Digital Innovation and the Infection Innovation Consortium, it creates a unique matrix, supporting new collaborations and growth.